Lectil

Betahistine Dihydrochloride, the active ingredient in Lectil, is a histamine H1 receptor agonist / H3 receptor antagonist presented as an oral formulation for oral use. It is used to manage vestibular disorders such as Meniere's disease and vertigo in adults and is prescribed by physicians to improve inner ear microcirculation and reduce associated symptoms.

GNH USA supplies Lectil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance and reliable global distribution networks.

Lectil (betahistine dihydrochloride) is employed in the management of vestibular disorders affecting inner‑ear function. - Meniere's disease: reduces frequency and severity of attacks by improving inner ear microcirculation. - Vertigo: alleviates spinning sensations through histamine‑mediated vascular effects. - Vestibular disorders: enhances balance function by increasing histamine release in the vestibular nuclei.

Betahistine may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Gastric irritation: mild abdominal discomfort.

Serious or Rare Side Effects: - Allergic reaction: urticaria, swelling, or anaphylaxis. - Arrhythmia: irregular heart rhythm. - Severe hypotension: marked blood pressure drop.

When prescribing betahistine, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: adjust use in patients with severe kidney dysfunction. - Cardiovascular disease: monitor for arrhythmias or blood pressure changes. - Pregnancy: evaluate risk‑benefit as safety data are limited. - Concomitant antihistamines: avoid concurrent use with strong H1 antagonists that may reduce efficacy. - Elderly patients: start at lower dose and monitor for dizziness. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Betahistine can interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid): - Strong H1 antihistamines: may counteract betahistine’s action. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive episodes.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may increase vestibular side effects. - Diuretics: may alter inner‑ear fluid balance. - Anticoagulants: monitor for increased bleeding risk.